Altered States of Consciousness and Psychedelic Science
How to read this page: This article maps the topic from beginner to expert across six levels � Remembering, Understanding, Applying, Analyzing, Evaluating, and Creating. Scan the headings to see the full scope, then read from wherever your knowledge starts to feel uncertain. Learn more about how BloomWiki works ?
Altered States of Consciousness and Psychedelic Science is the "Study of the Modified Mind"—the investigation of the "Neuroscientific and Psychological Field" (~2010s–Present, though "Ancient Practices" go "Back" "Millennia") of "Non-ordinary States" of "Consciousness" (Psychedelics, Meditation, Dreaming, Flow States, NDEs) and their "Therapeutic, Creative, and Philosophical" "Implications." While "Traditional Psychiatry" (see Article 109) "Treats" "Disorders" with "Specific Drug Targets," **Psychedelic Science** "Broadens" the "Landscape" of "Mind" and "Healing." From "Psilocybin Trials" and "Default Mode Network Suppression" to "Mystical Experience" and "Therapeutic Mechanisms," this field explores the "Architecture of Unrestricted Awareness." It is the science of "Cognitive Liberation," explaining why "Breaking the Patterns" of "Normal Consciousness" "Can" **"Heal Trauma"** and **"Expand Understanding."**
Remembering[edit]
- Altered State of Consciousness (ASC) — Any "Mental State" "Significantly Different" from "Normal Waking Consciousness" in "Terms of Perception," "Cognition," or "Emotion."
- Psilocybin — The "Active Compound" in "'Magic Mushrooms'": a **"Serotonergic Psychedelic"** "That" "Binds" to **5-HT2A Receptors** and "Dramatically Alters" "Consciousness."
- LSD — (Lysergic acid diethylamide). "A Synthetic" **"Psychedelic"** (see Albert Hofmann, 1943) "With" "Extremely High Potency" and "Long Duration."
- DMT — (Dimethyltryptamine). "The Most Potent" **"Psychedelic"** — also "Produced" "Endogenously" (in the Body). "Associated with" **"Near-Death Experiences"** (NDEs).
- Default Mode Network (DMN) — (See Article 712). The "Brain Network" "Active" "During" "Self-Referential Thought" (Rumination, Mind-wandering): **"Suppressed"** by "Psychedelics," "Potentially" "Breaking" "Rigid Thought Patterns."
- ENTROPY Theory — (Robin Carhart-Harris). "Psychedelics" "Increase" **"Brain Entropy"** (Complexity / Disorder), "Loosening" "Habitual" "Cognitive Patterns."
- Mystical Experience — A "Characteristic" "Peak Experience" of "Psychedelics" involving "Unity," "Sacredness," "Noetic Quality," and "Transcendence of Time and Space."
- Ketamine — "A Dissociative Anesthetic" with "Rapid" **"Anti-Depressant Effects"** "Via NMDA Receptor Antagonism": "First" "Approved" "Psychedelic-Adjacent Drug."
- MDMA — (Empathogen/Entactogen). "Currently" in "Phase 3 Trials" for **"PTSD Treatment"**: "Promotes" "Openness" and "Trust" During "Trauma Processing."
- The 'Default Mode Network' Ego — "The Neural" "Substrate" of "The Self-Story": **"Psychedelics"** "Dissolve" it, "Leading" to "Ego Dissolution."
Understanding[edit]
Altered states are understood through Entropy and Healing.
1. The "Loosened" Filter (ENTROPY Theory): "Opening the Reducing Valve."
- (See Article 110). **Aldous Huxley** (1954) "Called" the "Brain" a **"Reducing Valve"** — "It Blocks" "Most" of "Reality" to "Allow" "Functional Survival."
- **Psychedelics** "Open" the "Valve," "Flooding" "Consciousness" with "More" "Information" (Higher Entropy).
- This "Disrupts" **"Rigid Patterns"** like "Depression's Negative Self-Talk" or "PTSD's Fear Loops."
- "Healing" is **"Disorder."**
2. The "Mystical" Therapeutic Mechanism (Healing): "The Trip that cures."
- (See Article 109). **Psilocybin** "Therapy" for **Depression** "Shows" "Remarkable" "Remission Rates" (60-70% at 6 months in Johns Hopkins studies).
- "The Key" "Seems" to be the **"Mystical Experience"** — "A Sense" of "Unity," "Oceanic Boundlessness," and "Sacredness."
- This "Changes" the **"Patient's Relationship"** to "Their Illness" and "Their Self."
- "The Cure" is **"A Story."**
3. The "DMN Reset" (Mechanism): "Rebooting the Operating System."
- (See Article 712). The **DMN** is the **"Ego Network"** — it "Generates" the "Narrative Self."
- **Psychedelics** "Suppress" the "DMN," "Allowing" **"Other Networks"** to "Communicate" "More Freely."
- This is like **"Rebooting a Computer"**: "Old Programs" (Habits, Fears) **"Are Lost"** and the "Mind" is "Open" to **"New Configurations."**
- "Change" is **"Disintegration."**
The 'MAPS' MDMA-PTSD Trial (2021)': A "Phase 3" "Clinical Trial" "Showed" that **"67% of MDMA-assisted Therapy Participants"** "No Longer Met Criteria" for **PTSD** "After" "Treatment," "Compared" to "32% in Placebo." It proved that "Altered States" "Are" "Legitimate Medicine."
Applying[edit]
Modeling 'The Therapeutic Window' (Mapping 'Entropy' to 'Therapeutic Benefit'): <syntaxhighlight lang="python"> def evaluate_psychedelic_therapy(brain_entropy_score, therapeutic_set_and_setting):
"""
Shows how 'Entropy' and 'Context' create healing.
"""
# Both too low (no effect) and too high (overwhelming) entropy reduce benefit
# Optimal range is a 'sweet spot'
if brain_entropy_score < 0.3:
benefit = 0
msg = "NO EFFECT: Entropy too low. Normal consciousness. Sub-therapeutic dose."
elif 0.3 <= brain_entropy_score <= 0.7:
benefit = brain_entropy_score * therapeutic_set_and_setting
msg = f"THERAPEUTIC WINDOW: Optimal entropy. Benefit score: {round(benefit, 2)}"
else:
benefit = (1 - brain_entropy_score) * therapeutic_set_and_setting
msg = f"CHALLENGING: High entropy. Requires support. Benefit: {round(benefit, 2)}"
return msg
- Case: A psilocybin session with moderate dose and strong therapeutic setting
print(evaluate_psychedelic_therapy(0.55, 0.9)) </syntaxhighlight>
- Clinical Landmarks
- Johns Hopkins Psilocybin Center → The "World's Leading" "Research Institution" for **"Psilocybin Therapy"** (Depression, Addiction, End-of-Life Anxiety).
- The 'Imperial College' COMPASS Trial → (See Article 109). "UK-Based" "Trials" "Confirming" "Psilocybin's" "Non-Inferiority" to **"SSRIs."**
- Oregon's Measure 109 (2020) → The "First" "US State" to "Legalize" **"Supervised Psilocybin Services"** for "Adults."
- The 'MAPS' Phase 3 MDMA Trials → "FDA" "Breakthrough Therapy" "Designation" for **"PTSD"** — the "First" "Scheduled Substance" "Nearing Approval" in "50 years."
Analyzing[edit]
| Feature | Standard Psychiatry (Daily Pill) | Psychedelic Therapy (The Journey) |
|---|---|---|
| Mechanism | "Chronic receptor modulation (SSRIs)" | "Acute state change + integration" |
| Duration | "Ongoing (Years of treatment)" | "Limited (1-3 sessions + therapy)" |
| Target | "Symptom Management" | "Root Cause / Traumatic Memory" |
| Side Effects | "Blunted emotion, dependence, sexual dysfunction" | "Challenging experiences (With proper set/setting)" |
| Analogy | 'Daily medication' | 'A guided vision quest' |
The Concept of "Set and Setting": Analyzing "The Context." (See Article 114). **Timothy Leary** (1964) "Argued" that the **"Quality"** of "A Psychedelic Experience" is "Determined" as much by **"Mindset"** (Set) and **"Environment"** (Setting) as by the "Drug Itself." "Modern Neuroscience" "Confirms" this: "Context" "Shapes" the **"Attractor Landscape"** of a "High-Entropy Brain." "The Context" is **"The Medicine."**
Evaluating[edit]
Evaluating Psychedelic Science:
- Safety: How do we "Ensure" **"Equitable Access"** and "Prevent" "Commercial Exploitation" of "Sacred Plants"?
- Mechanism: Is the **"Mystical Experience"** "Necessary" for "Therapeutic Benefit," or just "Correlated"?
- Regulation: How should we "Regulate" **"Legal Psychedelic Services"** in a "Responsible" "Way"?
- Impact: How will "Psychedelic Research" "Change" our **"Model of the Self"** (see Article 711)?
Creating[edit]
Future Frontiers:
- The 'Therapeutic' AI Guide: (See Article 08). An AI that "Monitors" a "Patient's" **"Brain State"** in "Real-Time" and "Adjusts" the "Music and Setting" to "Optimize" the "Therapeutic Arc."
- VR 'Consciousness' Explorer: (See Article 604). A "VR Experience" that "Simulates" the **"Visual and Phenomenological"** "Features" of "Altered States" "Without" a "Drug."
- The 'Psychedelic' Therapy Ledger: (See Article 533). A "Blockchain" for **"Safely Archiving"** "Anonymized Session Data" for "Global Therapeutic Research."
- Global 'Mind Freedom' Accord: (See Article 630). A "Planetary Agreement" to "Recognize" **"Cognitive Liberty"** — the "Right" to "Explore" "One's Own Consciousness."